LncRNA APTR amplification serves as a potential glioma biomarker and promotes glioma progression via miR-6734-5p/ TCF7/LEF1 axis
We identified APTR as a novel prognostic biomarker in patients with gliomas and confirmed that APTR is a ceRNA that promotes glioma progression via the APTR/miR-6734-5p/TCF7/LEF1 axis.
Authors
- Lin Yu (ORCID: https://orcid.org/0000-0002-9972-3799)
- Wenjun Luo (ORCID: https://orcid.org/0000-0003-2811-1848)
- Ming‐Yii Huang (ORCID: https://orcid.org/0000-0001-9432-5284)
- Heng Chen (ORCID: https://orcid.org/0000-0002-4466-2239)
- Shanshan Zhang (ORCID: https://orcid.org/0000-0003-2760-8377)
- Cuiyun Sun
- Jiayi Li (ORCID: https://orcid.org/0009-0003-7430-5261)
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Non-coding RNA Research
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1016/j.ncrna.2025.02.007
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Natural Science Foundation of China